KBTBD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.575800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.541610E-01
Normal-vs-Stage2
7.577200E-01
Normal-vs-Stage3
2.459200E-01
Normal-vs-Stage4
5.930000E-01
Stage1-vs-Stage2
3.947400E-01
Stage1-vs-Stage3
5.669400E-01
Stage1-vs-Stage4
2.082000E-01
Stage2-vs-Stage3
2.464600E-01
Stage2-vs-Stage4
2.416600E-01
Stage3-vs-Stage4
1.474220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.000200E-01
Normal-vs-AfricanAmerican
9.824400E-01
Normal-vs-Asian
7.796400E-01
Caucasian-vs-AfricanAmerican
4.445600E-01
Caucasian-vs-Asian
9.412400E-01
AfricanAmerican-vs-Asian
6.867000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.198600E-01
Normal-vs-Female
7.220600E-01
Male-vs-Female
4.861200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.916800E-01
Normal-vs-Age(41-60Yrs)
8.021800E-01
Normal-vs-Age(61-80Yrs)
4.449800E-01
Normal-vs-Age(81-100Yrs)
2.876400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.551400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.618600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.109200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.594900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.378500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.447400E-01
Normal-vs-Daily Drinker
3.890000E-01
Normal-vs-Weekly Drinker
4.737800E-01
Normal-vs-Occasional Drinker
9.350800E-01
Normal-vs-Social Drinker
8.771000E-01
Non Drinker-vs-Daily Drinker
8.308200E-01
Non Drinker-vs-Weekly Drinker
9.674400E-01
Non Drinker-vs-Occasional Drinker
1.096410E-01
Non Drinker-vs-Social Drinker
2.641800E-01
Daily Drinker-vs-Weekly Drinker
8.937000E-01
Daily Drinker-vs-Occasional Drinker
9.459600E-02
Daily Drinker-vs-Social Drinker
2.159400E-01
Weekly Drinker-vs-Occasional Drinker
1.885000E-01
Weekly Drinker-vs-Social Drinker
3.392800E-01
Occasional Drinker-vs-Social Drinker
6.884800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.927200E-01
Normal-vs-Grade 2
5.276000E-01
Normal-vs-Grade 3
4.927800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.093380E-01
Grade 1-vs-Grade 3
3.520300E-02
Grade 1-vs-Grade 4
2.927200E-01
Grade 2-vs-Grade 3
3.031800E-01
Grade 2-vs-Grade 4
5.276000E-01
Grade 3-vs-Grade 4
4.927800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.876000E-01
Normal-vs-NonDiabetic
6.412200E-01
Diabetic-vs-NonDiabetic
4.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.390000E-01
Normal-vs-NoPancreatitis
6.170600E-01
Pancreatitis-vs-NoPancreatitis
9.055000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.529400E-01
Normal-vs-N1
7.710400E-01
N0-vs-N1
1.441600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.304000E-01
Normal-vs-TP53-NonMutant
4.134000E-01
TP53-Mutant-vs-TP53-NonMutant
3.027800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
